Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hydreight Technologies Inc ( (TSE:NURS) ) has provided an announcement.
At its 2025 Annual General Meeting, Hydreight Technologies Inc. announced that all proposed items of business were approved by shareholders, including the election of director nominees and the fixed omnibus equity incentive plan. The plan allows for the issuance of up to 9,000,000 common shares through various equity-based awards, pending final approval from the TSX Venture Exchange. The reappointment of key executives, including CEO Shane Madden, underscores the company’s strategic continuity.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. operates in the technology sector, focusing on providing innovative solutions. The company is involved in the development and implementation of equity-based incentive plans and has a presence on multiple stock exchanges, including TSXV, OTC, and FSE.
Average Trading Volume: 350,483
Technical Sentiment Signal: Buy
Current Market Cap: C$115.8M
See more insights into NURS stock on TipRanks’ Stock Analysis page.